Measurement of cellular DNA content and c-erbB1 amplification seem to have prognostic value in squamous cell carcinoma of the head and neck  Rodrigo Tapia JP. Martinez Sanchez JA. Sanchez Lazo P. Ramos S. Sampedro Nuno A. Suarez Nieto C Acta Otorrinolaringol Esp 47: 97-103 (1996)  

The erbB oncogenes as prognostic markers in oral squamous cell carcinomas. Werkmeister R. Brandt B. Joos U Am J Surg 172: 681-3 JC (1996)  

E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma. Jones JL. Royall JE. Walker RA. Br J Cancer 74: 1237-1241 (1996)  

Expression analyses of  EGFR and HER-2/neu  Beckmann MW. Niederacher D. Massenkeil G. Tutschek B. Beckmann A. Schenko G. Schnurch HG. Bender HG. Oncology 53: 441-447 (1996)  

Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers  Brandt B. Vogt U. Schlotter CM. Jackisch C. Werkmeister R. Thomas M. von Eiff M. Bosse U. Assmann G. Zanker KS Gene 159: 35-42 (1995)  

Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts  Kokai-Y. Myers-J-N. Wada-T. Brown-V-I. LeVea-C-M. Davis-J-G. Dobashi-K. Greene-M-I. Cell 58: 287-292 (1989) 

Defective v-erbB genes can be complemented by v-erbA in erythroblast and fibroblast transformation  Jansson-M. Beug-H. Gray-C. Graf-T. Vennstrom-B. Oncogene 1: 167-173 (1987)  

v-erbA cooperates with sarcoma oncogenes in leukemic cell transformation  Kahn-P. Frykberg-L. Brady-C. Stanley-I. Beug-H. Vennstrom-B. Graf-T. Cell 45: 349-356 (1986)  

EGF activates calcium channels by phospholipase A2/5-lipoxygenase-mediated leukotriene C4 production.  Peppelenbosch-M-P. Tertoolen-L-G. den-Hertog-J. de-Laat-S-W. Cell 69: 295-303 (1992)  

Intermolecular association of the p185neu protein and EGFR modulates EGFR function  Wada-T. Qian-X-L. Greene-M-I. Cell 61: 1339-1347 (1990) 

The bovine papillomavirus E5 transforming protein can stimulate the transforming activity of EGF and CSF-1 receptors  Martin-P. Vass-W-C. Schiller-J-T. Lowy-D-R. Velu-T-J. Cell 59: 21-32 (1989)  

EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling  Margolis-B. Rhee-S-G. Felder-S. Mervic-M. Lyall-R. Levitzki-A. Ullrich-A. Zilberstein-A. Schlessinger-J. Cell 57: 1101-1107 (1989)  

Phospholipase C-gamma is a substrate for the PDGF and EGF receptor  protein-tyrosine kinases in vivo and in vitro  Meisenhelder-J. Suh-P-G. Rhee-S-G. Hunter-T. Cell 57: 1109-1122 (1989) 

Amplification of oncogene c-erb-B1 and cellular DNA content in squamous cell carcinoma of the head and neck  Rodrigo Tapia JP. Martinez Sanchez JA. Sanchez Lazo P. Ramos S. Sampedro Nuno A. Suarez Nieto C Acta Otorrinolaringol Esp 47: 97-103 (1996)  

Alterations in the level of phosphotyrosine signal transduction constituents in human parotid tumors Bu R. Purushotham KR. Kerr M. Tao Z. Jonsson R. Olofsson J. Humphreys-Beher MG Proc Soc Exp Biol Med 211: 257-264 (1996)  

Expression of c-erbB family gene products in adenoid cystic carcinoma of salivary glands   Shintani S. Funayama T. Yoshihama Y. Alcalde RE. Ootsuki K. Terakado N. Matsumura T Anticancer Res 15: 2623-2626 (1995)  

c-erbB-2 oncogene expression in salivary gland tumours  Karja V. Syrjanen S. Kataja V. Syrjanen K ORL J Otorhinolaryngol Relat Spec 56: 206-212 (1994)  

Expression of the ERBB2 protein in benign and malignant salivary gland tumors  Stenman G. Sandros J. Nordkvist A. Mark J. Sahlin P Genes Chromosomes Cancer 3: 128-135 (1991)  

Immunohistochemical localization of c-myc oncogene product and EGF receptor in oral squamous cell carcinoma  Sakai H. Kawano K. Okamura K. Hashimoto N J Oral Pathol Med 19: 1-4 (1990) 

The activated c-erbB which lacks the amino-terminal extracellular domain but which retains the entire carboxy-terminal sequences is leukemogenic but not sarcomagenic. Pelley-R-J. Moscovici-C. Hughes-S. Kung-H-J. J-Virol 62: 1840-1844 (1988)  

Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene Velu-T-J. Beguinot-L. Vass-W-C. Willingham-M-C. Merlino-G-T. Pastan-I. Lowy-D-R. Science 238: 1408-1410 (1987)  

Epidermal growth factor receptor protein tyrosine kinase associated with the plasma membrane as one target for ionizing radiation in the dose range used in radiotherapy  Schmidt-Ullrich RK. Valerie K. Fogleman PB. Walters J. Radiat Res 145: 81-85 (1996)  

Potent inhibition of breast cancer cell lines by the isoflavonoid kievitone: comparison with genistein Hoffman R. Biochem Biophys Res Commun 211: 600-606 (1995)  

Wild-type human p53 activates the human epidermal growth factor receptor promoter  Deb SP. Munoz RM. Brown DR. Subler MA. Deb S. Oncogene 9: 1341-1349 (1994)  

Signal transduction by the epidermal growth factor receptor is attenuated by a COOH-terminal domain serine phosphorylation site  Theroux-S-J. Latour-D-A. Stanley-K. Raden-D-L. Davis-R-J. J-Biol-Chem 267: 16620-6 (1992)  

Ligand-activated thyroid hormone and retinoic acid receptors inhibit growth factor receptor promoter expression  Hudson-L-G. Santon-J-B. Glass-C-K. Gill-G-N. Cell 62: 1165-1175 (1990)  

alteration of EGF binding and EGF-induced growth-regulatory gene expression  Takehara-K. LeRoy-E-C. Grotendorst-G-R. Cell 49: 415-422 (1987)  

Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing  Honegger-A-M. Dull-T-J. Felder-S. Van-Obberghen-E. Bellot-F. Szapary-D. Schmidt-A. Ullrich-A. Schlessinger-J. Cell 51: 199-209 (1987)